1.48
Calidi Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
0.79
FY23:
4.30
FY24:
10.2
FY25:
6.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
230
FY22:
1.81
FY23:
5.72
FY24:
3.96
FY25:
2.60
Total assets
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
2.60
FY23:
10.0
FY24:
14.2
FY25:
8.86
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.41
FY22:
43.0
FY23:
10.2
FY24:
9.50
FY25:
3.94
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.0
FY22:
0.45
FY23:
8.02
FY24:
2.72
FY25:
1.16
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.7
FY22:
−50.4
FY23:
−8.24
FY24:
1.53
FY25:
3.76
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
10.0
FY24:
13.7
FY25:
8.86
All amounts in millions USD